article thumbnail

From Lab to C-Suite: The Future of Life Sciences Consulting

Tom Spencer

In recent years, there have been large M&A deals involving pharmaceutical and biotechnology companies, and a significant area of expansion in the technology space – health tech. The global life sciences consulting market is expected to grow by around 10% per year from 2024 to 2029. What is life sciences consulting?

article thumbnail

How to Get Yourself Invited to Important Meetings

Harvard Business

She was on the legal compliance team at a fast-growing biotechnology company. In fact, she was not brought into the discussion until campaigns were far along in their development and it was too late for her to influence the marketing team’s decisions. Do You Really Need to Hold That Meeting? Elizabeth Grace Saunders.

Meeting 134
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Top 10 Consulting Firms in San Francisco

Management Consulted

In addition, BCG hosts combined Training & Development events between the San Francisco and Palo Alto offices to incorporate team-building across offices and engage them in learning together. The San Francisco office has also developed a strong learning culture. The firm was ranked No. Deloitte Consulting , 101 Market St.,

article thumbnail

Innovation Should Be a Top Priority for Boards. So Why Isn’t It?

Harvard Business

Only 13% of directors in the energy and utilities industry consider innovation to be a major strategic challenge, but the swift growth of renewable energy companies and such developments as the use of drones for monitoring oil and gas production suggest that no industry is impervious to the forces of innovation.

article thumbnail

The Promise and Challenge of Big Data for Pharma

Harvard Business

The emergence of big data, as well as advancements in data science approaches and technology, is providing pharmaceutical companies with an opportunity to gain novel insights that can enhance and accelerate drug development. This information will ultimately support critical drug development decisions.

Data 70
article thumbnail

The Reason Silicon Valley Beat Out Boston for VC Dominance

Harvard Business

In contrast, New England has increasingly become a hub for ventures in life sciences; the first three-quarters of 2016 saw almost 60% of VC investments in New England go to ventures in biotechnology and medical devices. You need to be plugged into the local informal networks. Doing so requires being there.

article thumbnail

Companies Can Address Talent Shortages by Partnering with Educators

Harvard Business

” “Our goal,” it stated, “must be to develop the talents of all to their fullest.” The talents of all are not being developed to their fullest, and many U.S. ” Unfortunately, this goal hasn’t been met. industries face acute skills shortages.